Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus‐seropositive women

Abstract

Recurrence rates of CIN after standard treatment in HIV-positive women are high, and recurrence is related to immune status in this high-risk group. Therapeutic strategies that address these treatment failures should be developed for HIV-seropositive women.